Adjuvant effect of anti-4-1BB mAb administration in adoptive T cell therapy of cancer
<p>Administration of anti-4-1BB mAb has been found to be a potent adjuvant when combined with other therapeutic approaches, e.g. chemotherapy, cytokine therapies, anti-OX40 therapy, and peptide or DC vaccines. However, the adjuvant effect of anti-4-1BB mAb administration in adoptive T cell the...
Main Author: | Qiao Li, Takekazu Iuchi, Maria N. Jure-Kunkel, Alfred E. Chang |
---|---|
Format: | Article |
Language: | English |
Published: |
Ivyspring International Publisher
2007-01-01
|
Series: | International Journal of Biological Sciences |
Online Access: | http://www.biolsci.org/v03p0455.htm |
Similar Items
-
Studies on CD40mAb-adjuvanted conjugate vaccines
by: Sultana, Tessabelle
Published: (2014) -
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs.
by: Marnie L Fusco, et al.
Published: (2015-06-01) -
The Different Colors of mAbs in Solution
by: Alexandre Ambrogelly
Published: (2021-05-01) -
Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs.
by: Marnie L Fusco, et al.
Published: (2015-10-01) -
The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs
by: Josée Golay, et al.
Published: (2020-10-01)